PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation : LONGITUDINAL STUDY OF PATIENTS UNDERGOING RADIOFREQUENCY ABLATION OF ATRIAL FIBRILLATION.
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 750
- 试验地点
- 1
- 主要终点
- Incidence of atrial fibrillation recurrence.
研究概览
简要总结
Atrial fibrillation ablation is the most common intervention performed worldwide. Up to 20 to 45% of patients show recurrence of AF within 12 month after catheter ablation, however its determinant are incompletely understood.
The aim of the PROSPECT-AF study is to assess the predictors of AF recurrence within the 3 years following ablation using clinical variables and innovative biomarkers in a prospective cohort of 750 patients undergoing atrial fibrillation catheter ablation.
The secondary aims are to assess the incidence of major adverse cardiovascular outcomes (MACE) and the incidence of major bleeding within the 3 years Wolfing catheter ablation.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient undergoing atrial fibrillation catheter ablation
- •Able to give their consent
排除标准
- •Patient under guardianship
- •Patients unable to give their consent
- •Pregnancy
研究组 & 干预措施
Patients undergoing atrial fibrillation catheter ablation
Patients undergoing scheduled atrial fibrillation catheter ablation.
干预措施: atrial fibrillation catheter ablation (Procedure)
结局指标
主要结局
Incidence of atrial fibrillation recurrence.
时间窗: At 3 years
次要结局
- Incidence of major adverse cardiovascular events (MACE) including hospitalization for acute heart failure, cardiovascular death, stroke, myocardial infarction(At 3 years)
- Incidence of major bleeding (defined by BARC≥3 bleeding)(At 3 years)